(0.30%) 5 115.04 points
(0.24%) 38 331 points
(0.32%) 15 979 points
(-1.07%) $82.95
(4.94%) $2.02
(0.25%) $2 353.00
(0.45%) $27.66
(3.75%) $956.65
(-0.22%) $0.933
(-0.33%) $10.99
(-0.55%) $0.796
(1.65%) $93.39
@ $3.11
Utstedt: 14 feb 2024 @ 19:43
Avkastning: -16.08%
Forrige signal: feb 14 - 17:27
Forrige signal:
Avkastning: 3.15 %
Live Chart Being Loaded With Signals
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology...
Stats | |
---|---|
Dagens volum | 150 219 |
Gjennomsnittsvolum | 1.54M |
Markedsverdi | 96.66M |
EPS | $0 ( 2024-03-12 ) |
Neste inntjeningsdato | ( $-0.730 ) 2024-06-10 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.420 |
ATR14 | $0.00700 (0.27%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-15 | O'neill Vincent | Sell | 2 250 | Restricted Stock Units |
2024-03-15 | O'neill Vincent | Buy | 2 250 | Common Stock |
2024-04-04 | O'neill Vincent | Sell | 165 | Common Stock |
2024-03-14 | O'neill Vincent | Sell | 521 | Restricted Stock Units |
2024-03-14 | O'neill Vincent | Buy | 521 | Common Stock |
INSIDER POWER |
---|
-8.71 |
Last 87 transactions |
Buy: 187 774 | Sell: 228 648 |
Volum Korrelasjon
BioXcel Therapeutics Inc Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
AGNC | 0.927 |
NWL | 0.905 |
BOCH | 0.904 |
PRAX | 0.896 |
YQ | 0.896 |
SLVO | 0.894 |
GRFS | 0.893 |
SHYF | 0.891 |
CASS | 0.888 |
CLPS | 0.888 |
10 Mest negative korrelasjoner | |
---|---|
CRSA | -0.937 |
LONE | -0.906 |
PPBT | -0.903 |
SNCR | -0.902 |
TSLA | -0.897 |
MVBF | -0.882 |
TLMD | -0.88 |
EPZM | -0.878 |
RMRM | -0.876 |
MTEK | -0.876 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
BioXcel Therapeutics Inc Korrelasjon - Valuta/Råvare
BioXcel Therapeutics Inc Økonomi
Annual | 2023 |
Omsetning: | $1.38M |
Bruttogevinst: | $-198 000 (-14.35 %) |
EPS: | $-6.15 |
FY | 2023 |
Omsetning: | $1.38M |
Bruttogevinst: | $-198 000 (-14.35 %) |
EPS: | $-6.15 |
FY | 2022 |
Omsetning: | $375 000 |
Bruttogevinst: | $355 000 (94.67 %) |
EPS: | $-6.13 |
FY | 2021 |
Omsetning: | $0.00 |
Bruttogevinst: | $0.00 (0.00 %) |
EPS: | $0 |
Financial Reports:
No articles found.
BioXcel Therapeutics Inc
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. Its commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. The company also continues to conduct clinical trials evaluating BXCL501 for the treatment of agitation in Alzheimer's disease patients, and for adjunctive treatment of patients with major depressive disorder, as well as in the community for agitation associated with bipolar disorders and schizophrenia. In addition, it is developing BXCL502 as a potential therapy for chronic agitation in dementia; and BXCL701, an investigational, orally administered, systemic innate immunity activator for the treatment of aggressive forms of prostate cancer and advanced solid tumors that are refractory or treatment naïve to checkpoint inhibitors. The company was incorporated in 2017 and is headquartered in New Haven, Connecticut.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.